Enhanced Clarity for Myopic Children Through MiSight 1 day
by Optoplus / August 2024
Good news for parents of children with myopia: CooperVision® Canada has recently expanded its prescription range for MiSight® 1 day contact lenses. This expansion enables more children to access this innocative, specially designed lensaimed at controlling the progression of myopia.
Broadening the Prescription Spectrum
CooperVision Canada has extended the available prescriptions for MiSight® 1 day contact lenses from -0.25D to -10.00D. With this enhancement, 99.97% of age-appropraite children who have myopia—with astigmatism less than 1D—can now receive this treatment1. These lenses, designed specifically for children, have been clinically proven to effectively slow the progression of myopia.
The Critical Importance of Managing Myopia
As myopia incidence increases worldwide, effective interventions become crucial. Each dioptre unaddressed can lead to significant complications in adulthood, such as myopic maculopathy* and glaucoma.Enrique Contreras, Country Manager . CooperVision Canada , highlights that even older children who start using these lenses experience a reduction in myopia progression by up to 50%2.
A Robustly Researched Solution
MiSight® 1 day contact lenses are backed by one of the most longest-running studies on pediatric contact lenses ever conducted. The findings confirm that these lenses halve myopia progression 2§, regardless of the child’s age at initiation. Additionally, the research indicates no rebound effects 3,4,¶ after treatment cessation, ensuring lasting benefits.
Availability in All OPTOPLUS Optometry Clinics
MiSight® 1 day lenses are now available in all OPTOPLUS visual clinics across Quebec. Our optometrists, experts in myopia management, are ready to guide your children in preserving their vision. Don’t hesitate to consult an OPTOPLUS eye care professional and learn how these contact lenses can transform your child’s visual health.
For more information, please visit our website or the nearest OPTOPLUS visual clinic.
*Glossary
Myopic macular degeneration, or myopic maculopathy, is a severe complication of myopia. It involves the stretching of the retina, damaging the macula, and can lead to central vision loss. This condition predominantly affects younger people.
Source: Association Québécoise de la Dégénérescence Maculaire
*USA Indications for Use: MiSight® 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
- Using measured and modeled data, pooled across ages (8-17), MiSight® 1 day slowed myopia progression by an average of approximately 50%.
¶ On average, for children aged 8-15 at start of wear. Instead, eye growth reverted to expected, age average myopic progression rates.
1. CVI Data on file, 2022. SERE coverage of childhood myopia prescriptions with MiSight® 1 day for 104,810 eyes in Asia (China, Korea) and 116,336 eyes in Europe and USA aged 8-18 years.
2. Arumugam B, Bradley A, Hammond D, Chamberlain P. Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2333.
3. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. Optom Vis Sci 2021;98:E-abstract 210049.
4. Hammond D, Arumugam B, et al. Myopia Control Treatment Gains are Retained after Termination of Dual-focus Contact Lens Wear with no Evidence of a Rebound Effect. Optom Vis Sci 2021;98:E-abstract 215130.
Share this article
